Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, Safety and Pharmacokinetic Study of Single Doses of DFN-15 in Post-Surgical Dental Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2022
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 01 Jan 2022 Primary endpoint (Summed Pain Intensity Difference over the first six hours) has been met as per results published in the Pain
- 01 Jan 2022 Results published in the Pain
- 24 Oct 2019 Status changed from active, no longer recruiting to completed.